Interestingly, activation of the Akt pathway rescued the effect of magnolol in BRAF‐ and NRAS‐mutant melanoma cells suggesting magnolol might primarily be acting through the PI3K/Akt pathway (Figure 3A). This evidence concerns the gene BRAF and melanoma.